These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 1626940)

  • 61. Clinical trial of iproplatin (cis-dichloro-trans-dihydroxy-bis-isopropylamine platinum IV, CHIP) in patients with advanced breast cancer.
    Casper ES; Smart TC; Hakes TB; Ochoa M; Kaufman RJ
    Invest New Drugs; 1988 Jun; 6(2):87-91. PubMed ID: 3049433
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Phase II study of 5'-deoxy-5-fluorouridine (5'-DFUR) in patients with malignant cancer--a multi-institutional cooperative study].
    Niitani H; Kimura K; Saito T; Nakao I; Abe O; Urushizaki I; Ohta K; Yoshida Y; Kimura T; Kurihara M
    Gan To Kagaku Ryoho; 1985 Oct; 12(10):2044-51. PubMed ID: 2932059
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Late phase II study of KW-2307 in advanced or recurrent breast cancer. KW-2307 Cooperative Study Group (Breast Cancer Section)].
    Tominaga T; Nomura Y; Adachi I; Aoyama H; Nagao K; Mitsuyama S; Nakamura Y; Ogita M; Sano M; Takashima S
    Gan To Kagaku Ryoho; 1994 May; 21(6):809-16. PubMed ID: 8185338
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Carminomycin study in breast cancer].
    Lichinitser MR; Assekritova IV; Gorbunova VA; Arseriĭ SA; Vaarik KhM
    Antibiotiki; 1978 May; 23(5):453-7. PubMed ID: 350145
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Phae II study of hexamethylmelamine in women with advanced breast cancer refractory to standard cytotoxic therapy.
    Denefrio JM; Vogel CL
    Cancer Treat Rep; 1978 Jan; 62(1):173-5. PubMed ID: 414835
    [No Abstract]   [Full Text] [Related]  

  • 66. [Clinical trial of 5'-deoxy-5-fluorouridine (5'-DFUR) in advanced cancer patients].
    Irie K; Yasutake K; Imamura Y; Yoshimura Y; Yoshida M; Nakamura T; Suehiro I
    Gan To Kagaku Ryoho; 1985 Dec; 12(12):2371-8. PubMed ID: 2934026
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Phase I clinical study of oxaliplatin].
    Taguchi T; Tsukagoshi S; Furue H; Niitani H; Noda K
    Gan To Kagaku Ryoho; 1998 Oct; 25(12):1899-907. PubMed ID: 9797812
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Phase I study of spiroplatin.
    Tanis BC; Vermorken JB; ten Bokkel Huinink WW; Klein I; Gall H; van Oosterom AT; Simonetti G; McVie JG; van der Vijgh WJ; Pinedo HM
    Eur J Cancer; 1991; 27(3):268-73. PubMed ID: 1827311
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Platinum drugs].
    Kusaba H; Baba E
    Nihon Rinsho; 2015 Feb; 73 Suppl 2():143-5. PubMed ID: 25831739
    [No Abstract]   [Full Text] [Related]  

  • 70. Phase II study of amonafide in advanced breast cancer.
    Scheithauer W; Dittrich C; Kornek G; Haider K; Linkesch W; Gisslinger H; Depisch D
    Breast Cancer Res Treat; 1991 Dec; 20(1):63-7. PubMed ID: 1813070
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Phase I clinical trial and pharmacokinetics of carboplatin (NSC 241240) by single monthly 30-minute infusion.
    Koeller JM; Trump DL; Tutsch KD; Earhart RH; Davis TE; Tormey DC
    Cancer; 1986 Jan; 57(2):222-5. PubMed ID: 3510700
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Phase I study of weekly-administered iproplatin [cis-dichloro-trans-dihydroxy-bis-isopropylamine platin (chip, JM9)].
    Chawla SP; Yap BS; Tenney DM; Bodey GP; Benjamin RS
    Invest New Drugs; 1988 Dec; 6(4):311-7. PubMed ID: 3229943
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Phase II study of teniposide in advanced breast cancer.
    Boas J; Rasmussen D; Hansen OP; Engelholm SA; Dombernowsky P
    Cancer Chemother Pharmacol; 1990; 25(6):463-4. PubMed ID: 2311176
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Phase I study of cis-dichloro-trans-dihydroxy-bis(isopropylamine)platinum IV (CHIP).
    Ribaud P; Gouveia J; Misset JL; Mathé G
    Oncology; 1986; 43(2):78-82. PubMed ID: 3951788
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Co-operative clinical evaluation of 5'-DFUR tablets for breast cancer at 31 institutions].
    Morimoto K; Taguchi T; Ohta J; Miura S; Ueda N; Yayoi K; Inaji H
    Gan To Kagaku Ryoho; 1992 Jul; 19(7):1041-8. PubMed ID: 1385688
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Phase II study of iproplatin (CHIP, JM-9) in advanced testicular cancers progressing after prior chemotherapy.
    Clavel M; Monfardini S; Gundersen S; Kaye S; Siegenthaler P; Renard J; van Glabbeke M; Pinedo HM
    Eur J Cancer Clin Oncol; 1988 Aug; 24(8):1345-8. PubMed ID: 3181255
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Phase II trial of the oral platinum complex JM216 in non-small-cell lung cancer: an EORTC early clinical studies group investigation.
    Judson I; Cerny T; Epelbaum R; Dunlop D; Smyth J; Schaefer B; Roelvink M; Kaplan S; Hanauske A
    Ann Oncol; 1997 Jun; 8(6):604-6. PubMed ID: 9261531
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Prediction from creatinine clearance of thrombocytopenia and recommended dose in patients receiving (glycolato-O,O')-diammine platinum (II) (NSC 375101D).
    Sasaki Y; Fukuda M; Morita M; Shinkai T; Eguchi K; Tamura T; Ohe Y; Yamada K; Kojima A; Nakagawa K
    Jpn J Cancer Res; 1990 Feb; 81(2):196-200. PubMed ID: 2110134
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Phase II study of intravenous menogaril in patients with advanced breast cancer.
    Sessa C; Gundersen S; ten Bokkel Huinink W; Renard J; Cavalli F
    J Natl Cancer Inst; 1988 Sep; 80(13):1066-9. PubMed ID: 2970554
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Hydroxy 9-methyl 2-ellipticinium acetate (NSC 264-137). Toxicologic study and therapeutic effect in 100 cancers (author's transl)].
    Juret P; Tanguy A; Girard A; Le Talaer JY; Abbatucci JS; Dat-Yuong ; Le Pecq JB; Paoletti C
    Nouv Presse Med; 1979 Apr; 8(18):1495-8. PubMed ID: 471724
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.